Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The Proportion of APOE4 Carriers Among Non-Demented Individuals: A Pooled Analysis of 389,000 Community-Dwellers.

Journal of Alzheimer's disease : JAD - 1 Jan 2021

Wang Ya-Yu, Ge Yi-Jun, Tan Chen-Chen, Cao Xi-Peng, Tan Lan, Xu Wei

Abstract excerpt

BACKGROUND: The apolipoprotein E epsilon 4 (APOE4) is the strongest genetic risk factor for sporadic Alzheimer's disease (AD). Its carriage percentage in non-demented population varies across geographic regions and ethnic groups. OBJECTIVE: To estimate the proportion of APOE4 (2/4, 3/4, or 4/4) carriers in non-demented community-dwellers. METHODS: PubMed, EMBASE, and China National Knowledge Infrastructure were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alleles
Share to Alzheimer Disease
Share to Apolipoprotein E4

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Databases, Genetic

Share to Heterozygote

Share to Polymorphism, Single Nucleotide

Source

Identifiers

PMID: 33935087
DOI: 10.3233/JAD-201606

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The Proportion of APOE4 Carriers Among Non-Demented Individuals: A Pooled Analysis of 389,000 Community-Dwellers.PMID 33935087Read ↗

Prevalence of apolipoprotein E4 genotype and homozygotes (APOE e4/4) among patients diagnosed with Alzheimer's disease: a systematic review and meta-analysis.Semantic proximity Read ↗

APOE-ε4 carriership and dementia risk over 10 years among Asian American and White older adults.Semantic proximity Read ↗

Apolipoprotein E ε4 prevalence in Alzheimer's disease patients varies across global populations: a systematic literature review and meta-analysis.Semantic proximity Read ↗

Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease.Semantic proximity Read ↗

APOE4 is a Risk Factor and Potential Therapeutic Target for Alzheimer's DiseaseSemantic proximity Read ↗

APOE Genotype and Alzheimer Disease Risk Across Age, Sex, and Population Ancestry.Semantic proximity Read ↗

The proportion of Alzheimer’s disease attributable to apolipoprotein ESemantic proximity Read ↗

Association of Uncommon, Noncoding Variants in the APOE Region With Risk of Alzheimer Disease in Adults of European Ancestry.Semantic proximity Read ↗

Variation in APOE ε4 Prevalence and Brain Health Associations by European Descent in White All of Us ParticipantsSemantic proximity Read ↗

<i>APOE</i> stratified genome-wide association studies provide novel insights into the genetic etiology of Alzheimers’s diseaseSemantic proximity Read ↗

Predictive value of APOE-ε4 allele for progression from MCI to AD-type dementia: a meta-analysis.Semantic proximity Read ↗

The Effect of the APOE ε2ε4 Genotype on the Development of Alzheimer's Disease (AD) and Mild Cognitive Impairment (MCI) in Non-Latino Whites.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.